Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)

<p dir="ltr">Patients with coronavirus disease (COVID-19) commonly experience distressing and challenging respiratory symptoms. Interventions such as oxygen therapy, oral opiates, and traditional nebulizers like ipratropium bromide and salbutamol are variable in their efficacy, and t...

Full description

Saved in:

Bibliographic Details
Main Author:	Nissar Shaikh (11659441) (author)
Other Authors:	Mohamad Y. Khatib (11659459) (author), Mohammad A. Al Wraidat (21322907) (author), Ahmed S. Mohamed (11659456) (author), Anood A. Al-Assaf (21322910) (author), Abdul Gafoor M. Tharayil (21322913) (author), Ahmad A. Abujaber (14586054) (author), Abdulqadir J. Nashwan (11659453) (author)
Published:	2022
Subjects:	Biomedical and clinical sciences Clinical sciences Pharmacology and pharmaceutical sciences Health sciences Epidemiology cough COVID-19 dyspnea nebulized fentanyl normal saline 0.9% throat pain
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)

Similar Items